✦ LIBER ✦

Retrospective analysis of the efficacy and safety of adalimumab 40 mg e.o.w. in patients with moderate to severe plaque psoriasis in a range of treatment duration from 4 to 52 months

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of adalimumab in a 1

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Secukinumab efficacy and safety outcomes

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Short- and long-term efficacy and safety

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

A randomized study to evaluate the effic

✍ Lebwohl, Mark G.; Kircik, Leon; Callis Duffin, Kristina; Pariser, David; Hooper, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Secukinumab efficacy and safety in subje

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Efficacy and safety of efalizumab in pat

✍ NAYAK, A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 27 KB